Exiqon and MultiD Sign Development and Distribution Agreement for microRNA qPCR Analysis Solution
News May 26, 2010
Exiqon A/S and MultiD Analyzes AB have announced a Development and Distribution Agreement incorporating a specifically adapted version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform. The agreement allows Exiqon to sell a fully compatible and comprehensive data analysis solution to complete their microRNA qPCR offering.
“The partnership between MultiD and Exiqon has lead to the development of a customized version of the advanced GenEx data analysis program which has been specifically adapted to allow easy pre-processing and analysis of data from the Exiqon microRNA PCR panels and assays,” said Henrik M. Pfundheller, VP Sales & Marketing of Exiqon.
Pfundheller continued, “Exiqon offers the best performing qPCR reagents for microRNA expression profiling on the market. However, we feel it is just as important that our customers process, normalize and analyze their qPCR data properly and with confidence. The addition of the Exiqon GenEx software to our microRNA qPCR portfolio enables customers to get the most out of their microRNA expression profiling experiments in an easy and convenient way”.
MultiD's GenEx software is well established software for processing and analysis of qPCR data. It includes everything from selection and validation of reference genes, data pre-processing and advanced statistical methods to analyze real-time qPCR data with simple clicks of the mouse. Possibly the most important part of qPCR experiments is the pre-processing of raw data for subsequent statistical analysis. Pre-processing steps need to be performed with consistence, in the correct order and with confidence.
Exiqon's miRCURY LNA™ Universal RT microRNA PCR system offers the best available combination of performance and ease-of-use on the microRNA real-time PCR market. The use of two LNA™-enhanced PCR primers results in both sensitivity and specificity, enabling quantification of very low microRNA levels and discrimination between closely related microRNA sequences.
The universal RT step reduces sample input requirements and technical variation, and saves time in the laboratory. The product line includes microRNA Ready-to-Use PCR panels for sensitive expression profiling of 730 human microRNAs, individual microRNA assays, reference gens and reagent kits.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE